|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/17 | |
| A61K 38/17 | |||
| A61P 7/00 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| C07K 14/725 | |||
| C12N 5/0783 |
| (11) | Patento numeris | 3307877 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16808492.9 |
| Europos patento paraiškos padavimo data | 2016-06-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/037120 |
| Data | 2016-06-12 |
| (87) | Numeris | WO 2016/201394 |
| Data | 2016-12-15 |
| (30) | Numeris | Data | Šalis |
| 201562175003 P | 2015-06-12 | US |
| (72) |
DROPULIC, Boro, US
ORENTAS, Rimas, US
SCHNEIDER, Dina, US
KRUEGER, Winfried, US
|
| (73) |
Lentigen Technology, Inc.,
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878,
US
|
| (54) | METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |
| METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |